Studies on compounds with antioxidant activity - Development of hypoglycemic agents, troglitazone (CS-045)

Yakugaku Zasshi

Volumn 117, Issue 9, 1997, Pages 597-610

  Yoshioka, Takao ^a   Fujita, Takashi ^b  

^a Chemtech Labo Inc   (Japan)

^b Research Institute of Sankyo   (Japan)

Author keywords

Antioxidant; CS 045; NIDDM; Noscal; Thiazolidine; Troglitazone

Indexed keywords

ANTIDIABETIC AGENT; CIGLITAZONE; ENGLITAZONE; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; THIAZOLIDINE DERIVATIVE; TOCOPHEROL; TROGLITAZONE;

AGING; ANIMAL CELL; ANTIOXIDANT ACTIVITY; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER WEIGHT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0030689010     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.117.9_597     Document Type: Review

References (63)

1. a) Horikoshi H., Yoshioka T., Kawasaki T., Nakamura K., Matsunuma N., Yamaguchi K., Sasahara K., (Annu. Rep. Sankyo Res. Lab.,), 46, 1-57 (1994)
2. b) Horikoshi H., Fujiwara T., Yoshioka T., Yoshioka S., Wada M., Fukami M., Frontiers in diabetes research, Lessons from animal diabetes III., ed. by Shafrir E., VI. 8, Smith-Gordon and Co., Ltd. 1990, pp. 320-324.
3. c) (J. Clin. Therap. & Med), 9, suppl., 3, 1993, -CS-045
4. d) Horikoshi H., Yoshioka T., D.D.T.
5. a) Glavind J., Hartmann S., Clemmesen J., Jessen K. E., Dam H., Acta Pathol. Microbiol Scand., 30, 1-6 (1952)
6. b) Stephens N. G., Parsons A., Schofleld P. M., Kelly F., Cheeseman K., Mitchinson M. J., Brown M. J., Lancet, 347, 781 (1996).
7. a) Fujita T., Yoshioka T., 208th ACS Nat. Meet. Div. Med. Chem., # 136, Washington, DC., Aug. 1994
8. b) Fujita T., Watanabe H., Iwaoka T., Yoshioka T., American Diabetes Association, 32nd Research Symposium, The Role of Oxidant and Antioxidant Therapy in Diabetic Complications, # 19, p. 46, Nov. 15, 1996, Orlando, Florida.
9. b) Baynes J. W., "Role of oxidation chemistry in the Maillard reaction in vivo., In The Maillard Reaction in Biological Systems," Ikan R. ed. by John Wiley, New York, pp. 55-72 (1996)
10. c) Thorpe S. R., Baynes J, W., Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs & Aging, 9, 69-77 (1996)
11. d) Fu M-X., Fu S., Dean R., Thorpe S. R., Baynes J. W., American Diabetes Association, 32nd Research Symposium, The Role of Oxidant and Antioxidant Therapy in Diabetic Complications, # 37, p. 59, Nov. 15-17, 1996, Orland, Florida.
12. c) Fujita T., Yoshioka T., Medicinal Chemistry: Today and Tomorrow, (Proc. AFMC Internat. Med. Chem. Sympo. (AIMECS '95)), p. 75, Sept., 1995, Tokyo, (Blackwell Science, Oxford).
13. b) Toda T., Kurumada T., Murayama K., 187th ACS Meet. Div. Polymer Chem., ACS Symp. Series 280, # 3, Progress in the Light Stabilization of Polymers, St. Louis, Apr. 1984.
14. b) Fukuzawa K., Suzuki Y., Uchiyama M., Chem. Pharm. Bull., 17, 1771-1777 (1969).
15. [Chem, Abstr., 98, 4391z (1983)].
16. Goto G., Okamoto K., Okutani T., Imada I., Chem. Pharm. Bull., 33, 4422-4431 (1985).
17. Shiraishi M., Terao S., J. Chem. Soc., Perkin Trans, 1, 1983, 1591-1599.
18. a) Aizawa Y., Kanai T., Hasegawa K., Yamaguchi T., iizuka Y., Iwaoka T., Yoshioka T., J. Med. Chem., 33, 1491-1496 (1990)
19. b) Unpublished results
20. d) Sugiyama K., Suzuki Y., Aoyagi K., Tsurufuji S., ibid., 89 (1985).
21. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., Horikoshi H., J. Med. Chem., 32, 421-428 (1989).
22. a) Burton G. W., Le Page Y., Gabe E. J., Ingold K. U., J. Am. Chem. Soc., 102, 7791-7792 (1980)
23. b) Burton G. W., Ingold K. U., ibid. 103, 6472-6477 (1981)
24. c) Burton G. W., Doba T., Gabe E. J., Hughes L., Lee F. L., Prasad L., Ingold K. U., ibid., 107, 7053-7065 (1985).
25. a) Kawamatsu Y., Saraie T., Imamiya E., Nishikawa K., Hamuro Y., Arzneim,-Forsch. / Drug. Res., 30(1), 454-459 (1980)
26. b) Kawamatsu Y., Asakawa H., Saraie T., Imamiya E., Nishikawa K., Hamuro Y., ibid., 585-589 (1980)
27. c) Kawamatsu Y., Asakawa H., Saraie T., Mizuno K., Imamiya E., Nishikawa K., Hamuro Y., ibid., 751-758 (1980).
28. a) Sohda T., Mizuno K., Tawada H., Sugiyama Y., Fujita T., Kawamatsu Y., Chem. Pharm. Bull., 30, 3563-3573 (1982)
29. b) Sohda T., Mizuno K., Imamiya E., Sugiyama Y., Fujita T., Kawamatsu Y., ibid., 3580-3600 (1982).
30. Yoshioka T., Kanai T., Aizawa Y., Horikoshi H., Hasegawa K., US 4873255 (1989) [Chem, Abstr., 110, 23876u (1989)].
31. Yoshioka T., Kanai T., Aizawa Y., Horikoshi H., Hasegawa K., US 4873255 (1989) [Chem, Abstr., 110, 23876u (1989)].
32. Cantello B. C. C., Cawthorne M. A., Haigh D., Hindley R. M., Smith S. A., Thurlby P. L., Bioorg. Med.Chem. Lett., 4, 1181-1184 (1994).
33. Taylor J. D., Wolfe J. F., Synthesis, 1971, 310.
34. Fujiwara T., Yoshioka S., Yoshioka T., Ushiyama I., Horikoshi H., Diabetes, 37, 1549-1558 (1988).
35. b) Kuzuya T., Kosaka K., Akanuma Y., Shigeta Y., Kaneko T., Shimizu N., Diabetologia, 37, Suppl., 1, A63 (1994);
36. c) Hansen A. P., ibid., 38, Suppl., 1, A200 (1995);
37. d) Levin K., Thye R. P., Foot E., Beck N. H., ibid.. 38, Suppl. 1, A200 (1995).
38. Yoshioka S., Nishino H., Shiraki T., Ikeda K., Koike H., Okuno A., Wada M., Fujiwara T., Horikoshi H., Metabolism, 42, 75-80 (1993).
39. Fu Y., Sheu C., Fujita T., Foote C. S., Photochemistry and Photobiology, 63, 615 (1996).
40. Iwaoka T., Tabata F., Yoshioka T., Koga T., Saku K., WO-9419347 [Chem, Abstr., 122, 1084e (1995)].
41. Iwaoka T., Tabata F., Yoshioka T., Koga T., Saku K., WO-9419347 [Chem, Abstr., 122, 1084e (1995)].
42. b) Iwaoka T., Sano Y., Tabata F., Konse T., Kitazawa E., Yoshioka T., (in contribution).
43. b) Noguchi N., Sakai H., Kato Y., Tsuchiya J., Yamamoto Y., Niki E., Horikoshi H., Kodama T., Atherosclerosis. 123, 227 (1996)
44. c) Nagasawa Y., Kaku K., Nakamura K., Kaneko T., Biochem. Pharmacol., 50, 1109 (1995).
45. a) Quinn M. T., Parthasarathy S., Fong L. G., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 84, 2995-2998 (1987)
46. b) Witztum J. L., Steinberg D., J. Clin. Invest., 88, 1785-1792 (1991).
47. b) Fukuda M., Ikegami H., Ogihara T., ibid., 37, suppl., p. 178 (May 1994, Tokushima).
48. Ekoe J.-M., "Diabetes Mellitus," Elsevier, 1988, p 33, (p 39) New York.
49. a) Drug News Perspect 1996, 9(5), 293
50. b) Kadowaki T., DITN, 203, 8 (1997), Japan.